Press Releases - 2007
| November 26, 2007 Sanofi Pasteur supports National Influenza Vaccination Week. | More |
| November 13, 2007 Sanofi Pasteur and Acambis join forces to bring West Nile vaccine to market. | More |
| November 7, 2007 Sanofi Pasteur initiates phase II trial of cell culture-based seasonal influenza vaccine. | More |
| November 6, 2007 Sanofi Pasteur presents positive results of tetravalent dengue candidate vaccine. | More |
| October 19, 2007 Sanofi Pasteur receives FDA approval of meningococcal vaccine for children. | More |
| October 15, 2007 Sanofi Pasteur and Institut Pasteur team up against malaria. | More |
| September 18, 2007 Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at Low Dosage. | More |
| July 26, 2007 Sanofi pasteur President and CEO David J. Williams to retire; Wayne Pisano named President and CEO. | More |
| June 20, 2007 Sanofi pasteur announces completion of construction of new U.S. influenza vaccine manufacturing facility. | More |
| June 14, 2007 Sanofi pasteur awarded contract to retrofit influenza vaccine facility. | More |
| June 13, 2007 Sanofi pasteur supports WHO initiative for the establishment of an H5N1 vaccine stockpile. | More |
| April 18, 2007 Sanofi pasteur receives first U.S. license for a vaccine against avian influenza in humans. | More |
| August 13, 2007 Sanofi pasteur first manufacturer to ship doses of influenza vaccine for the 2007-2008 season. | More |
| February 27, 2007 The Vaccines and Related Biological Products Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend licensure of a 90 mcg H5N1 vaccine. | More |
| January 25, 2007 FDA Advisory Committee Recommends Licensure of New Pediatric Combination Vaccine | More |
Access to categories:
